Factors predictive of cerebral hyperperfusion after carotid angioplasty and stent placement
…, S Yoshimura, J Kokuzawa - American Journal of …, 2004 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Cerebral hyperperfusion syndrome has been increasingly
reported as a complication of carotid angioplasty and stent placement. The aim of the …
reported as a complication of carotid angioplasty and stent placement. The aim of the …
Microneurosurgical management of internal carotid artery bifurcation aneurysms
…, H Shen, K Ishii, A Karatas, H Lehto, J Kokuzawa… - Surgical neurology, 2009 - Elsevier
BACKGROUND: Internal carotid artery bifurcation aneurysms form 2% to 9% of all IAs. They
are more frequent in younger patients than other IAs. In this article, we review the practical …
are more frequent in younger patients than other IAs. In this article, we review the practical …
Hepatocyte growth factor promotes proliferation and neuronal differentiation of neural stem cells from mouse embryos
J Kokuzawa, S Yoshimura, H Kitajima… - Molecular and Cellular …, 2003 - Elsevier
Hepatocyte growth factor (HGF), originally cloned as a hepatocyte mitogen, has recently been
reported to exhibit neurotrophic activity in addition to being expressed in different parts of …
reported to exhibit neurotrophic activity in addition to being expressed in different parts of …
Microneurosurgical management of anterior choroid artery aneurysms
…, L Kivipelto, R Kivisaari, M Foroughi, J Kokuzawa… - World neurosurgery, 2010 - Elsevier
OBJECTIVE: Anterior choroid artery aneurysms (AChAAs) constitute 2%-5% of all intracranial
aneurysms. They are usually small, thin walled with one or several arteries originating at …
aneurysms. They are usually small, thin walled with one or several arteries originating at …
Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model
S Yoshimura, R Morishita, K Hayashi, J Kokuzawa… - …, 2002 - Am Heart Assoc
Although cerebral hypoperfusion caused by cerebral occlusive disease leads to cerebral
ischemic events, an effective treatment has not yet been established. Recently, a novel …
ischemic events, an effective treatment has not yet been established. Recently, a novel …
Follow-up study on in-stent thrombosis after carotid stenting using multidetector CT angiography
H Watarai, Y Kaku, M Yamada, J Kokuzawa, T Tanaka… - Neuroradiology, 2009 - Springer
Introduction The purpose of the present study was to evaluate the role of multidetector three-dimensional
computed tomography angiography (3D CTA) for evaluating both the residual …
computed tomography angiography (3D CTA) for evaluating both the residual …
Surgical treatment of complex cerebral aneurysms using interposition short vein graft
…, H Takei, M Miyai, K Yamashita, J Kokuzawa - Trends in …, 2016 - Springer
Background and Aims Cerebral revascularization strategies may become necessary in select
patients who present with challenging cerebral aneurysms. In this study, we present the …
patients who present with challenging cerebral aneurysms. In this study, we present the …
Neuronal protein NP25 interacts with F-actin
K Mori, Y Muto, J Kokuzawa, T Yoshioka… - Neuroscience …, 2004 - Elsevier
Neuronal protein NP25 is a neuron-specific protein present in highly differentiated neural
cells, but its functional properties have not been well characterized. NP25 shows high amino …
cells, but its functional properties have not been well characterized. NP25 shows high amino …
STA-MCA/STA-PCA bypass using short interposition vein graft
…, M Tsujimoto, K Yamashita, J Kokuzawa - Trends in Neurovascular …, 2014 - Springer
Background and aims: Superficial temporal artery (STA) is the mainstay of donor vessels for
extra-intracranial bypass (EC-IC bypass) in cerebral revascularization. However, the …
extra-intracranial bypass (EC-IC bypass) in cerebral revascularization. However, the …
Culture method for the induction of neurospheres from mouse embryonic stem cells by coculture with PA6 stromal cells
H Kitajima, S Yoshimura, J Kokuzawa… - Journal of …, 2005 - Wiley Online Library
Embryonic stem (ES) cells proliferate and maintain their pluripotency for over 1 year in vitro
and may therefore provide a sufficient source for cell therapies. However, most of the …
and may therefore provide a sufficient source for cell therapies. However, most of the …